Skip to main content

Posard Matthew L.

In the past year, 1 open-market sale filing worth $2.05M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$2.05M
1 filing
Net
−$2.05M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Posard Matthew L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

HALO Halozyme Therapeutics, Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 17, 2026 (view filing)5:19 PM ETSep 161 dayPosard Matthew L.DirectorSSale−19.0K$107.74−$2.05M−24.4%58.8K after4 lots10b5-1
Aug 14, 2024 (view filing)Aug 12-142 daysPosard Matthew L.DirectorSSale−29.9K$56.53−$1.69M−30.0%69.9K after3 lots
Jun 13, 2024 (view filing)Jun 11-122 daysPosard Matthew L.DirectorSSale−20.0K$50.32−$1.01M−16.7%99.8K after2 lots
Dec 6, 2022 (view filing)Dec 2-64 daysPosard Matthew L.DirectorSSale−30.0K$56.89−$1.71M−22.2%105.2K after3 lots

NAUT Nautilus Biotechnology, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 1, 2021 (view filing)Nov 30-Dec 11 dayPosard Matthew L.DirectorPPurchase+50.0K$4.51+$225.5KNew position50.0K after4 lots